Israel Englander Immunic, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Immunic, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 579,683 shares of IMUX stock, worth $579,683. This represents 0.0% of its overall portfolio holdings.

Number of Shares

579,683

Previous 99,837 480.63%

Holding current value

$579,683

Previous $164,000 253.05%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.0 - $1.61 $479,846 - $772,552	479,846 Added 480.63%	579,683 $579,000
Q3 2024 Nov 14, 2024	BUY	$1.08 - $1.95 $75,776 - $136,817	70,163 Added 236.45%	99,837 $164,000
Q2 2024 Aug 14, 2024	SELL	$0.98 - $1.44 $88,572 - $130,147	-90,380 Reduced 75.28%	29,674 $32,000
Q1 2024 May 15, 2024	BUY	$1.14 - $1.53 $136,861 - $183,682	120,054 New	120,054 $158,000
Q2 2023 Aug 14, 2023	SELL	$1.33 - $2.51 $424,038 - $800,253	-318,826 Reduced 25.21%	945,797 $2.37 Million
Q1 2023 May 15, 2023	BUY	$1.35 - $2.87 $719,656 - $1.53 Million	533,079 Added 72.87%	1,264,623 $1.88 Million
Q4 2022 Feb 14, 2023	SELL	$1.13 - $10.8 $538,953 - $5.15 Million	-476,950 Reduced 39.47%	731,544 $1.02 Million
Q3 2022 Nov 14, 2022	BUY	$3.0 - $5.49 $208,020 - $380,676	69,340 Added 6.09%	1,208,494 $3.82 Million
Q2 2022 Aug 15, 2022	BUY	$3.13 - $12.25 $1.92 Million - $7.53 Million	614,591 Added 117.16%	1,139,154 $3.95 Million
Q1 2022 May 16, 2022	SELL	$9.54 - $14.26 $440,156 - $657,927	-46,138 Reduced 8.08%	524,563 $5.93 Million
Q4 2021 Feb 14, 2022	BUY	$7.34 - $10.25 $554,390 - $774,182	75,530 Added 15.25%	570,701 $5.46 Million
Q3 2021 Nov 15, 2021	BUY	$8.05 - $13.29 $2.06 Million - $3.4 Million	255,615 Added 106.7%	495,171 $4.38 Million
Q2 2021 Aug 16, 2021	BUY	$11.76 - $16.85 $943,540 - $1.35 Million	80,233 Added 50.36%	239,556 $2.94 Million
Q1 2021 May 17, 2021	SELL	$14.21 - $25.3 $761,570 - $1.36 Million	-53,594 Reduced 25.17%	159,323 $2.54 Million
Q4 2020 Feb 16, 2021	SELL	$14.8 - $20.37 $1.77 Million - $2.44 Million	-119,696 Reduced 35.99%	212,917 $3.26 Million
Q3 2020 Nov 16, 2020	BUY	$11.74 - $22.0 $3.9 Million - $7.32 Million	332,613 New	332,613 $6.18 Million
Q2 2020 Aug 14, 2020	SELL	$5.67 - $15.86 $58,168 - $162,707	-10,259 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$4.22 - $9.8 $5,080 - $11,799	-1,204 Reduced 10.5%	10,259 $61,000
Q4 2019 Feb 14, 2020	SELL	$6.4 - $10.23 $3,033 - $4,849	-474 Reduced 3.97%	11,463 $111,000
Q3 2019 Nov 14, 2019	SELL	$10.0 - $17.01 $178,720 - $304,002	-17,872 Reduced 59.96%	11,937 $120,000
Q2 2019 Aug 15, 2019	SELL	$7.88 - $33.2 $36.3 Million - $153 Million	-4,612,664 Reduced 99.36%	29,809 $342,000
Q2 2019 Aug 14, 2019	BUY	$7.88 - $33.2 $36.6 Million - $154 Million	4,642,473 New	4,642,473 $254 Million

Others Institutions Holding IMUX

# of Institutions

Shares Held

49.5M

Call Options Held

184K

Put Options Held

307K

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $30.6M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account